ClinicalTrialsFinder

Immune Checkpoint Inhibitors Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

Immune Checkpoint InhibitorsLiver Injury
Zhejiang University2,000 enrolled1 locationNCT06402981